Clinical Trial Update: Effect on Glycemic Control of Inhaled Insulin Alone or Added to Dual Oral Therapy After Failure of Dual Oral Therapy. [Phase 3]

View source ↗

Summary

Phase 3 trial assessing inhaled insulin alone or added to dual oral therapy in adults with type 2 diabetes after failure of dual oral therapy; the study status …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Exubera (insulin inhalation powder)

Snippet

Sponsor: Pfizer | Conditions: Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED